Nokia Corp vs Twist Bioscience Corp — how do they compare? Nokia Corp trades at $10.97 (market cap $56.70B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Nokia Corp is far larger — about 10.4× Twist Bioscience Corp's market cap, and Nokia Corp pays a 1.63% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| NOK | TWST | |
|---|---|---|
Market Cap | $56.70B | $5.45B |
Sector | Technology | Health |
52-Week High | $16.83 | $102.88 |
52-Week Low | $4.05 | $24.16 |
Enterprise Value | $53.51B | $5.37B |
Dividend Yield | 1.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →